Skip to main content
Erschienen in: Acta Diabetologica 6/2013

01.12.2013 | Original Article

Association of incidence of type 1 diabetes with mortality from infectious disease and with antibiotic susceptibility at a country level

verfasst von: Alexia-Giovanna Abela, Stephen Fava

Erschienen in: Acta Diabetologica | Ausgabe 6/2013

Einloggen, um Zugang zu erhalten

Abstract

To investigate the association between country incidence of type 1 diabetes and mortality from infectious disease and antibiotic susceptibility. An ecological study to explore the relationship at a country level of the reported incidence of type 1 diabetes (DiaMond) to infectious disease mortality (World Health Organisation) and to antibiotic susceptibility (Alexander Project). There were significant negative correlations between the incidence of type 1 diabetes and mortality for all infectious diseases studied. There were also significant positive correlations between the incidence of type 1 diabetes and antibiotic susceptibilities of Strep. pneumoniae, but not to those of Haem. influenzae. Since infectious disease mortality and antibiotic susceptibility are surrogate markers for bacterial exposure, our results provide support for a negative association between bacterial exposure in a community and its incidence of type 1 diabetes. The consistency of our results as well as the highly statistically significant results of most of the associations studied reinforces the validity of our findings.
Literatur
1.
Zurück zum Zitat Skrivarhaug T, Bangstad HJ, Stene LC et al (2006) Long-term mortality in a nationwide cohort of childhood-onset type 1 diabetic patients in Norway. Diabetologia 49:298–305PubMedCrossRef Skrivarhaug T, Bangstad HJ, Stene LC et al (2006) Long-term mortality in a nationwide cohort of childhood-onset type 1 diabetic patients in Norway. Diabetologia 49:298–305PubMedCrossRef
2.
Zurück zum Zitat Dahlquist G, Kallen B (2005) Mortality in childhood-onset type 1 diabetes: a population-based study. Diabetes Care 28:2384–2387PubMedCrossRef Dahlquist G, Kallen B (2005) Mortality in childhood-onset type 1 diabetes: a population-based study. Diabetes Care 28:2384–2387PubMedCrossRef
3.
Zurück zum Zitat Törn C, Ingemansson S, Lindblad et al. DISS study group (2011) Excess mortality in middle-aged men with diabetes aged 15–34 years at diagnosis. Acta Diabetol 48(3):197–202. doi: 10.1007/s00592-011-0272-2 Törn C, Ingemansson S, Lindblad et al. DISS study group (2011) Excess mortality in middle-aged men with diabetes aged 15–34 years at diagnosis. Acta Diabetol 48(3):197–202. doi: 10.​1007/​s00592-011-0272-2
4.
Zurück zum Zitat Gale EA (2002) The rise of childhood type 1 diabetes in the 20th century. Diabetes 51:3353–3361PubMedCrossRef Gale EA (2002) The rise of childhood type 1 diabetes in the 20th century. Diabetes 51:3353–3361PubMedCrossRef
5.
Zurück zum Zitat Harrison LC, Honeyman MC, Morahan G et al (2008) Type 1 diabetes: lessons for other autoimmune diseases? J Autoimmun 31:306–310PubMedCrossRef Harrison LC, Honeyman MC, Morahan G et al (2008) Type 1 diabetes: lessons for other autoimmune diseases? J Autoimmun 31:306–310PubMedCrossRef
6.
Zurück zum Zitat Fsadni P, Fsadni C, Fava S, Montefort S (2012) Correlation of worldwide incidence of type 1 diabetes (DiaMond) with prevalence of asthma and atopic eczema (ISAAC). Clin Respir J 6:18–25PubMedCrossRef Fsadni P, Fsadni C, Fava S, Montefort S (2012) Correlation of worldwide incidence of type 1 diabetes (DiaMond) with prevalence of asthma and atopic eczema (ISAAC). Clin Respir J 6:18–25PubMedCrossRef
7.
Zurück zum Zitat Christen U, von Herrath MG (2005) Infections and autoimmunity: good or bad? J Immunol 174:7481–7486PubMed Christen U, von Herrath MG (2005) Infections and autoimmunity: good or bad? J Immunol 174:7481–7486PubMed
8.
Zurück zum Zitat D’Angeli MA, Merzon E, Valbuena LF, Tirschwell D, Paris CA, Mueller BA (2010) Environmental factors associated with childhood-onset type 1 diabetes mellitus: an exploration of the hygiene and overload hypotheses. Arch Pediatr Adolesc Med 164(8):732–738PubMedCrossRef D’Angeli MA, Merzon E, Valbuena LF, Tirschwell D, Paris CA, Mueller BA (2010) Environmental factors associated with childhood-onset type 1 diabetes mellitus: an exploration of the hygiene and overload hypotheses. Arch Pediatr Adolesc Med 164(8):732–738PubMedCrossRef
9.
Zurück zum Zitat Airaghi L, Tedeschi A (2006) Negative association between occurrence of type 1 diabetes and tuberculosis incidence at population level. Acta Diabetol 43:43–45PubMedCrossRef Airaghi L, Tedeschi A (2006) Negative association between occurrence of type 1 diabetes and tuberculosis incidence at population level. Acta Diabetol 43:43–45PubMedCrossRef
10.
Zurück zum Zitat Cardwell CR, Carson DJ, Patterson CC (2008) No association between routinely recorded infections in early life and subsequent risk of childhood-onset Type 1 diabetes: a matched case-control study using the UK General Practice Research Database. Diabet Med 25(3):261–267PubMedCrossRef Cardwell CR, Carson DJ, Patterson CC (2008) No association between routinely recorded infections in early life and subsequent risk of childhood-onset Type 1 diabetes: a matched case-control study using the UK General Practice Research Database. Diabet Med 25(3):261–267PubMedCrossRef
11.
Zurück zum Zitat Karvonen M, Viik-Kajander M, Moltchanova E, Libman I, LaPorte R, Tumilehto J (2000) Incidence of childhood type 1 diabetes worldwide. Diabetes Mondiale (DiaMond) Project Group. Diabetes Care 10:1516–1526CrossRef Karvonen M, Viik-Kajander M, Moltchanova E, Libman I, LaPorte R, Tumilehto J (2000) Incidence of childhood type 1 diabetes worldwide. Diabetes Mondiale (DiaMond) Project Group. Diabetes Care 10:1516–1526CrossRef
12.
Zurück zum Zitat Mathers CD, Bernard C, Iburg K, Inoue M, Ma Fat D, Shibuya K, Stein C, Tomijima, N (2003). The Global Burden of Disease in 2002: data sources, methods and results. Geneva, World Health Organization (GPE Discussion Paper No. 54). Available at http://www.who.int/evidence. Accessed 30/1/12 Mathers CD, Bernard C, Iburg K, Inoue M, Ma Fat D, Shibuya K, Stein C, Tomijima, N (2003). The Global Burden of Disease in 2002: data sources, methods and results. Geneva, World Health Organization (GPE Discussion Paper No. 54). Available at http://​www.​who.​int/​evidence. Accessed 30/1/12
14.
Zurück zum Zitat Jacobs MR, Felmingham D, Appelbaum PC, Grüneberg RN and the Alexander Project Group (2003) The Alexander Project 1998–2000: susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agents. J Antmicrob Chemother 52: 229–246 Jacobs MR, Felmingham D, Appelbaum PC, Grüneberg RN and the Alexander Project Group (2003) The Alexander Project 1998–2000: susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agents. J Antmicrob Chemother 52: 229–246
15.
Zurück zum Zitat The EuroDiab Investigators (2000) Infections and vaccinations as risk factors for childhood type I (insulin-dependent) diabetes mellitus: a multicentre case-control investigation. EURODIAB Substudy 2 Study Group. Diabetologia 43:47–53CrossRef The EuroDiab Investigators (2000) Infections and vaccinations as risk factors for childhood type I (insulin-dependent) diabetes mellitus: a multicentre case-control investigation. EURODIAB Substudy 2 Study Group. Diabetologia 43:47–53CrossRef
16.
Zurück zum Zitat Brugman S, Klatter FA, Visser JT et al (2006) Antibiotic treatment partially protects against type 1 diabetes in the Bio-Breeding diabetes-prone rat. Is the gut flora involved in the development of type 1 diabetes? Diabetologia 49(9):2105–2108PubMedCrossRef Brugman S, Klatter FA, Visser JT et al (2006) Antibiotic treatment partially protects against type 1 diabetes in the Bio-Breeding diabetes-prone rat. Is the gut flora involved in the development of type 1 diabetes? Diabetologia 49(9):2105–2108PubMedCrossRef
17.
Zurück zum Zitat Buschard K, Pedersen C, Hansen SV, Hageman I, Aaen K, Bendtzen K (1992) Anti-diabetogenic effect of fusidic acid in diabetes prone BB rats. Autoimmunity 14:101–104PubMedCrossRef Buschard K, Pedersen C, Hansen SV, Hageman I, Aaen K, Bendtzen K (1992) Anti-diabetogenic effect of fusidic acid in diabetes prone BB rats. Autoimmunity 14:101–104PubMedCrossRef
18.
Zurück zum Zitat Hviid A, Svanström H (2009) Antibiotic use and type 1 diabetes in childhood. Am J Epidemiol 169(9):1079–1084PubMedCrossRef Hviid A, Svanström H (2009) Antibiotic use and type 1 diabetes in childhood. Am J Epidemiol 169(9):1079–1084PubMedCrossRef
Metadaten
Titel
Association of incidence of type 1 diabetes with mortality from infectious disease and with antibiotic susceptibility at a country level
verfasst von
Alexia-Giovanna Abela
Stephen Fava
Publikationsdatum
01.12.2013
Verlag
Springer Milan
Erschienen in
Acta Diabetologica / Ausgabe 6/2013
Print ISSN: 0940-5429
Elektronische ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-013-0464-z

Weitere Artikel der Ausgabe 6/2013

Acta Diabetologica 6/2013 Zur Ausgabe

Consensus Paper

Trialogue Plus

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.